Clinical Trial: A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations

U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07325253) titled 'A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations' on Jan. 06.

Brief Summary: To study the safety and possible side effects of using the imaging agent 4-[18F]Fluoro-1-Naphthol (also called [18F]4FN) in PET/CT scans for participants with chronic GVHD.

Study Start Date: Nov. 18, 2025

Study Type: INTERVENTIONAL

Condition: Pilot Study PET/CT Imaging Host Disease Manifestation

Intervention: DRUG: [18F]-4FN

Given by IV

OTHER: PET-CT

Imaging

Recruitment Status: RECRUITING

Sponsor: M.D. Anderson Cancer Center

Published by HT Digital Content Services wi...